Squamous cell carcinoma of the lower lip in renal-transplant recipients: Report of six cases

International Journal of Oral and Maxillofacial Surgery

Volumn 26, Issue 2, 1997, Pages 120-123

  De Visscher, J G A M ^a   Bouwes Bavinck, J N ^b   Van Der Waal, I ^c  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immunosuppression; Kidney transplantation; Lip cancer; Squamous cell carcinoma

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIP TUMOR; MALE; MIDDLE AGED; RISK FACTOR; SKIN TUMOR; SMOKING; SQUAMOUS CELL CARCINOMA; SUNLIGHT;

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIP NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS; SMOKING; SUNLIGHT;

EID: 0031114436     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0901-5027(05)80831-8     Document Type: Article

References (33)

1. BARR BBB, BENTON EC, MCLAREN K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989: 1: 124-9.
2. BERKHOUT RJM, TIEBEN LM, SMITS HL, BOUWES BAVINCK JN, VERMEER BJ, TER SCHEGGET J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995: 33: 690-5.
3. BLOHME I. BRYNGER H. Malignant disease in renal transplant patients. Transplantation 1985: 39: 23-5.
4. BOUQUOT JE, GUNDLACH KKH. Odd lips: the prevalence of common lip lesions in 23,616 white Americans over 35 years of age. Quintessence Int 1987: 18: 277-84.
5. BOUWES BAVINCK JN, DE BOER A, VERMEER BJ, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients, Br J Dermatol 1993: 129: 242-9.
6. BOUWES BAVINCK JN, TIEBEN LM, VAN DER WOUDE FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995: 13: 1933-8,
7. CHEN J, KATZ RV, KRUTCHKOFF DJ, ElSENBERG E. Lip cancer. Incidence trends in Connecticut, 1935-1985. Cancer 1992: 70: 2025-30.
8. DARDANONI L, GAFÀ L. PATERNÒ R, PAVONE G. A case-control study on lip cancer risk factors in Ragusa (Sicily). Int J Cancer 1984: 34: 335-7.
9. DE JONG-TIEBEN LM, BERKHOUT RJM, SMITS HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995: 105: 367-71.
10. HARDIE IR, STRONG RW, HARTLEY LCJ, WOODRUFF PWH, CLUNIE CJA. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980: 87: 177-83.
11. HARRIS JP, PENN I. Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope 1981: 91: 520-8.
12. Ho M. Risk factors and pathogenesis of posttransplant lymphoproliferative disorders. Transplant Proc 1995: 27: 38-40.
13. HOOVER R, FRAUMENI JF JR. Risk of cancer in renal-transplant recipients. Lancet 1973: 2: 55-7.
14. KELLY GE, SHEIL AGR, TAYLOR R. Nonspecific immunological studies in kidney transplant recipients with and without skin cancer. Transplantation 1984: 37: 368-72.
15. KELLY JW, SABTO J, GURR FW, BRUCE F. Retinoids to prevent skin cancer in organ transplant recipients. Lancet 1991: 338: 1407.
16. KING GN, HEALY CM, GLOVER MT, et al. Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. N Engl J Med 1995: 332: 1052-7.
17. KORANDA FC, DEHMEL EM, KAHN G, PENN I. Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 1974: 229: 419-24.
18. LEGENDRE CM, GUTTMANN RD, YIP GH. Natural killer cell subsets in long-term renal allograft recipients. A phenotypie and functional study. Transplantation 1986: 42: 347-52.
19. LEVY JA. A new human herpesvirus: KSHV or HHV8? Lancet 1995: 346: 786.
20. MATAS AJ, SIMMONS RL, KJELLSTRAND CM, BUSELMEIER TJ, NAJARIAN JS, Increased incidence of malignancy during chronic renal failure, Lancet 1975; 1; 883-6.
21. MULLEN DL, SILVERBERG SG, PENN I, HAMMOND WS, Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 1976: 37: 729-34.
22. PENN I. The occurrence of malignant tumors in immunosuppressed states. Prog Allergy 1986: 37: 259-300.
23. PENN I. Cancer in the immunosuppressed organ recipient. Transplant Proc 1991: 23: 1771-2.
24. PENN I, Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993: 7: 431-45.
25. PUKKALA E, SÖDERHOLM AL, LINDQVIST C. Cancers of the lip and oropharynx in different social and occupational groups in Finland. Oral Oncol Eur J Cancer 1994: 30B: 209-15.
26. REGEV E, ZELTSER R, LUSTMANN J. Lip carcinoma in renal allograft recipient with long-term immunosuppressive therapy. Oral Surg 1992: 73: 412-4.
27. RÜDLINGER R, GROB R. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989: 1: 1132-3.
28. SCHUTTLEWORTH D, MARKS R, GRIFFIN PJA, SALAMAN JR. Treatment of cutaneous neoplasia with etretinate in renal transplant recipients. Q J Med 1988: 68: 717-24.
29. SHAMANIN V, GLOVER M, RAUSCH C, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994: 54: 4610-3.
30. SHEIL AGR, MAHONY JF, HORVATH JS, et al. Cancer following successful cadaveric renal transplantation. Transplant Proc 1981: 13: 733-5.
31. THOMAS DW, SEDDON SV, SHEPHERD JP. Systemic immunosuppression and oral malignancy: a report of a case and review of the literature. Br J Oral Maxillofac Surg 1993: 31: 391-3.
32. VAN DER LEEST RJ, ZACHOW KR, OsTROW RS, BENDER M, PASS F, FARAS AJ. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol 1987: 123: 345-7.
33. WIKLUND K, DICH J. Cancer risks among male farmers in Sweden. Eur J Cancer Prev 1995: 4: 81-90.